Back to WELLINGTON MANAGEMENT GROUP LLP WELLINGTON MANAGEMENT GROUP LLP

ACRVACRV
Showing 8 of 15 quarters

Position history for WELLINGTON MANAGEMENT GROUP LLPWELLINGTON MANAGEMENT GROUP LLP's holdings in ACRIVON THERAPEUTICS INC

WELLINGTON MANAGEMENT GROUP LLP holds 888,130 shares of ACRV (ACRIVON THERAPEUTICS INC), worth $1.6M as of 2026-Q2. ACRV represents 0.0% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.

Current Value

$1.6M

Current Shares

888,130

Total Value Change

-$4.6M

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
888,130
0.0%
$1.6M0.0%$1.78
0
2026-Q1
Unchanged
888,130
0.0%
$1.2M0.0%$1.67
0
2025-Q4
Unchanged
888,130
0.0%
$2.1M0.0%$2.44
0
2025-Q3
Unchanged
888,130
0.0%
$1.6M0.0%$1.82
0
2025-Q2
Unchanged
888,130
0.0%
$1.1M0.0%$1.20
0
2025-Q1
Unchanged
888,130
0.0%
$1.8M0.0%$2.24
0
2024-Q4
Unchanged
888,130
0.0%
$5.3M0.0%$5.41
0
2024-Q3
Unchanged
888,130
0.0%
$6.2M0.0%$7.16
0

Other major holders of ACRV: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used